Licensed Compound

Licensed Compound. Shall mean (i) any Available Compound that, as of the Effective Date, has already been designated as a Licensed Compound under the Prior Agreement or (ii) any Available Compound that the Research Committee designates as a Licensed Compound in accordance with Section 3.6.

Licensed Compound. Means [***]. For further clarity, if ROCHE terminates a Licensed Compound in one or more regions pursuant to Section 12.3, such Licensed Compound shall continue to be deemed a Licensed Compound except as provided in Article XII unless and until ROCHE terminates such Licensed Compound in all Regions pursuant to Section 12.3 (whether ROCHE so terminates such Licensed Compound in all Regions simultaneously or terminates such Licensed Compound in all Regions over time). For the sake of clarity, any... Licensed Compound shall also include all pro-drugs, metabolites, regioisomers, stereoisomers including enantiomers and diastereoisomers, salt forms, hydrates, solvates and polymorphs of such Licensed Compound, all of which shall constitute a single Licensed Compound. As of the Amendment Effective Date, the compounds identified in Appendix A are deemed to be Licensed Compounds and the compounds identified in Appendix B as Potential Licensed Compounds shall be deemed to be Licensed Compounds if such compounds have met the criteria set forth above on or before June 30, 2011. View More

Licensed Compound. Means any Available Compound or Inactive ArQule Compound that has been designated as a Licensed Compound as provided in Subsection 4.1.4 below.

Licensed Compound. Shall mean all of the compounds included within Licensed Compounds, as defined in Section 1.8 of the Agreement and, with respect to rights granted by LICENSORS to COMPANY under the SHIRE DAPD License, shall also include those compounds included within Licensed DAPD Compound.

Licensed Compound. Shall mean (i) all Directed Array Compounds, (ii) any ArQule Compound that the Research Committee designated as a Licensed Compound under the Prior Agreement, and (iii) any ArQule Compound that the Research Committee has designated as a Licensed Compound as provided in Section 3.1.2 below.

Licensed Compound. Means the compound that was designated by Astellas as ASP7266 (as further described in Exhibit A), together with all forms and components thereof.

Licensed Compound. Means a SCC that is licensed and provided by Redpoint to Givaudan pursuant to Section 15 of this Agreement.

Licensed Compound. A compound that inhibits the Target and that has a substantial therapeutic effect through such inhibition, and for which Teva has Exercised the License Option pursuant to the License Option Agreement and any derivative, future development or variation thereof that has such inhibitory properties, and that is comprised of, developed from, based on, or otherwise contain or incorporate the Company IP.

Licensed Compound. Biosimilar infliximab, a monoclonal antibody against TNF-a

Licensed Compound. Means Equivir and any metabolite, salt, ester, hydrate, solvate, isomer, enantiomer, free acid form, free base form, crystalline form, co-crystalline form, amorphous form, pro-drug (including ester pro-drug) form, racemate, polymorph, chelate, stereoisomer, tautomer, or optically active form of any of the foregoing.